You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atezolizumab

Showing 51 - 75 of 400
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Atezolizumab
  • +3 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Primary Peritoneal Carcinoma, PARP Inhibitor Trial in Pittsburgh

Not yet recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 8, 2022

Metastatic Cancer, Renal Cancer Trial in Indianapolis, Columbus, Philadelphia (Atezolizumab, Bevacizumab, Entinostat)

Suspended
  • Metastatic Cancer
  • Renal Cancer
  • Atezolizumab
  • +2 more
  • Indianapolis, Indiana
  • +3 more
Oct 29, 2022

Intrahepatic Cholangiocarcinoma Trial in Bad Saarow (Atezolizumab, Derazantinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Bad Saarow, Germany
    HELIOS KLinikum Bad Saarow
Jun 2, 2022

Unresectable Hepatocellular Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Chicago, Illinois
  • +6 more
Jan 18, 2023

HER2-positive Breast Cancer Trial in Philadelphia (Atezolizumab, Paclitaxel, Trastuzumab)

Suspended
  • HER2-positive Breast Cancer
  • Atezolizumab
  • +3 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 5, 2022

Urothelial Carcinoma Trial in United States (Atezolizumab, Bevacizumab)

Terminated
  • Urothelial Carcinoma
  • Phoenix, Arizona
  • +7 more
Dec 15, 2022

Carcinoma, Transitional Cell Trial in San Francisco (Atezolizumab)

Active, not recruiting
  • Carcinoma, Transitional Cell
  • Atezolizumab
  • San Francisco, California
    University of California, San Francisco
May 24, 2022

Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma, Stage III Adrenal Cortical Carcinoma AJCC v8

Not yet recruiting
  • Locally Advanced Adrenal Cortical Carcinoma
  • +4 more
  • Atezolizumab
  • +5 more
  • Atlanta, Georgia
  • +1 more
Aug 17, 2023

Oncology, Infusion Reaction Trial (Nivolumab, Pembrolizumab, Ipilimumab)

Not yet recruiting
  • Oncology
  • Infusion Reaction
  • (no location specified)
Sep 8, 2023

Triple Negative Breast Cancer, Stage IV Breast Cancer, HER2 Negative Trial in United States (Atezolizumab, Carboplatin,

Active, not recruiting
  • Triple Negative Breast Cancer
  • +3 more
  • Atezolizumab
  • +3 more
  • Washington, District of Columbia
  • +5 more
Dec 1, 2022

Bladder Cancer Trial in United States (Cabozantinib, Atezolizumab, Cystectomy)

Recruiting
  • Bladder Cancer
  • Hackensack, New Jersey
  • +4 more
Aug 26, 2022

Colorectal Cancer Metastatic Trial in Phoenix, Jacksonville, Rochester (PolyPEPI1018, Atezolizumab)

Recruiting
  • Colorectal Cancer Metastatic
  • Phoenix, Arizona
  • +2 more
Jun 28, 2022

Small-cell Lung Cancer, Brain Metastases Trial in United States (Carboplatin, Etoposide, Atezolizumab)

Active, not recruiting
  • Small-cell Lung Cancer
  • Brain Metastases
  • Duarte, California
  • +5 more
Oct 10, 2022

Tumor, Solid Trial in United States (BDB001, Atezolizumab)

Active, not recruiting
  • Tumor, Solid
  • Los Angeles, California
  • +4 more
Jul 6, 2022

Non Small Cell Lung Cancer Trial in Changsha (Atezolizumab)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Atezolizumab
  • Changsha, Hunan, China
    Hunan Cancer hospital
May 19, 2022

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

Active, not recruiting
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides/Sezary Syndrome
  • Atezolizumab
  • Madrid, Spain
  • +1 more
Jul 1, 2022

Squamous Cell Carcinoma of the Head and Neck, Anal Canal Cancer, Cervical Cancer Trial in France (biological, procedure, other,

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +2 more
  • Blood sample collection
  • +4 more
  • Besançon, France
  • +4 more
Nov 17, 2022

Urothelial Carcinoma, Locally Advanced, Unresectable Trial in United States (Atezolizumab, Gemcitabine, Cisplatin)

Active, not recruiting
  • Urothelial Carcinoma
  • +2 more
  • Atezolizumab
  • +2 more
  • Chicago, Illinois
  • +8 more
Dec 23, 2022

Advanced Solid Tumors, Metastatic Solid Tumors Trial in Duarte, Cheongju-si (GDC-1971, Atezolizumab, Omeprazole)

Recruiting
  • Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Duarte, California
  • +1 more
Aug 10, 2022

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Atezolizumab
  • +4 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Cisplatin, Carboplatin)

Active, not recruiting
  • Carcinoma, Small Cell Lung
  • Atezolizumab
  • +4 more
  • Beijing City, China
  • +7 more
Nov 24, 2022

SCLC,Extensive Stage Trial in Omaha (RYZ101 Dose Level 1, RYZ101 Dose Level 2, RYZ101 Dose Level 3)

Recruiting
  • SCLC,Extensive Stage
  • RYZ101 Dose Level 1
  • +6 more
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Nov 18, 2022

Non Small Cell Lung Cancer Trial in Durham (Atezolizumab, Bevacizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • Durham, North Carolina
    Duke University Medical Center
May 23, 2022

Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +10 more
  • Aurora, Colorado
  • +6 more
Jan 4, 2023